Skip to main content

lanreotide

Generic: LANREOTIDE ACETATE·Brand: LANREOTIDE ACETATE, SOMATULINE DEPOT, Somatuline

lanreotide: 3 clinical trials tracked.

lanreotide evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about lanreotide, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence3 indications · 1 study sponsors
Clinical Trial Registry Records (3)

A Randomized Phase III Blinded Trial of Lanreotide for the Prevention of Postoperative Pancreatic Fistula

NCT06807437Registry updated 2026-03-31·Phase 3
Recruiting

Primary endpoint: Incidence of postoperative pancreatic fistula (POPF)

InterventionalRandomizeddouble274 targetStarted 2025-05Completion 2027-1150 sites · United StatesSWOG Cancer Research Network

Phase 1b/3 Global, Randomized, Controlled, Open-label Trial Comparing Treatment With RYZ101 to Standard of Care Therapy in Subjects With Inoperable, Advanced, SSTR+, Well-differentiated GEP-NETs That Have Progressed Following Prior 177Lu-SSA Therapy

NCT05477576Registry updated 2026-03-30·Phase 3·RYZB
Recruiting

Primary endpoint: Phase 1b: RP3D

InterventionalRandomizedopen338 targetStarted 2022-03Completion 2030-1250 sites · Belgium, Brazil, Canada, France…RayzeBio, Inc.

A Phase I/II Study Using Cabozantinib and Lanreotide as Treatment for Advanced Gastroenteropancreatic Neuroendocrine Tumors That Failed Molecular Targeted Therapies or Chemotherapy (SCALET)

NCT05048901Registry updated 2026-04-09·Phase 1/Phase 2
Recruiting

Primary endpoint: to determine the maximal tolerated dose of cabozantinib

Interventionalopen49 targetStarted 2021-09Completion 2027-1211 sites · TaiwanNational Health Research Institutes, Taiwan